Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212085 | SCV000209581 | benign | not specified | 2014-06-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000159598 | SCV000215925 | likely benign | Hereditary cancer-predisposing syndrome | 2014-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000231198 | SCV000283085 | benign | Ataxia-telangiectasia syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000159598 | SCV000687839 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212085 | SCV000916560 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000231198 | SCV001264111 | uncertain significance | Ataxia-telangiectasia syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Sema4, |
RCV000159598 | SCV002529890 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-05 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000212085 | SCV004024611 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589652 | SCV005083696 | benign | Familial cancer of breast | 2024-06-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Institute for Biomarker Research, |
RCV000159598 | SCV005415575 | likely benign | Hereditary cancer-predisposing syndrome | 2024-09-16 | criteria provided, single submitter | clinical testing | The synonymous variant NM_000051.4(ATM):c.8532T>C (p.Ile2844=) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Ile2844= variant is observed in 6/113,572 (0.0053%) alleles from individuals of gnomAD Non Finnish European background in gnomAD. The p.Ile2844= variant is predicted to introduce a novel splice site by 1 of 4 splice site algorithms. The p.Ile2844= variant results in a substitution of a base that is not predicted conserved by GERP++ and PhyloP. For these reasons, this variant has been classified as Likely Benign. |
Genome Diagnostics Laboratory, |
RCV001580007 | SCV001809342 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001580007 | SCV001953375 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004551365 | SCV004766124 | likely benign | ATM-related disorder | 2019-12-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |